BioCardia (BCDA) FCF Margin Growth (3y) (2016 - 2024)
Powered by 
Analysis
BioCardia (BCDA) FCF Margin Growth (3y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | -63,107.00 |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | 4.25 Mn |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | 12,129.00 |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | 190,033.00 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -1.35 Mn |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 86,497.00 |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn | 10,262.00 |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | 371.00 |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -3.96 Mn |
| Mar 31, 2024 | 137,036.00 |
| Dec 31, 2023 | -681,020.00 |
| Sep 30, 2023 | 999,202.00 |
| Jun 30, 2023 | 136,003.00 |
| Mar 31, 2023 | 387,385.00 |
| Dec 31, 2022 | -131,390.00 |
| Sep 30, 2022 | -18,376.00 |
| Jun 30, 2022 | 242,471.00 |
| Mar 31, 2022 | -373,667.00 |
| Dec 31, 2021 | -65,170.00 |
| Sep 30, 2021 | 207,326.00 |
| Jun 30, 2021 | -301,326.00 |
| Mar 31, 2021 | -262,403.00 |
| Dec 31, 2020 | -487,426.00 |
| Sep 30, 2020 | -929,534.00 |
| Jun 30, 2020 | -679,349.00 |
| Mar 31, 2020 | -617,998.00 |
| Dec 31, 2019 | 32,042.00 |
| Sep 30, 2019 | 20,272.00 |